{
    "organizations": [],
    "uuid": "fbd6a93f08379bc945fff61f8635c7458bc3a265",
    "author": "",
    "url": "https://www.reuters.com/article/brief-glaxosmithkline-new-data-from-phas/brief-glaxosmithkline-new-data-from-phase-iii-clinical-trial-with-fluarix-tetra-idUSFWN1QO0AS",
    "ord_in_thread": 0,
    "title": "BRIEF-Glaxosmithkline New Data From Phase III Clinical Trial With Fluarix Tetra",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 6, 2018 / 11:03 AM / in 26 minutes BRIEF-Glaxosmithkline New Data From Phase III Clinical Trial With Fluarix Tetra Reuters Staff 1 Min Read March 6 (Reuters) - Glaxosmithkline Plc: * ANNOUNCED NEW DATA FROM PHASE III CLINICAL TRIAL WITH FLUARIX TETRA WHICH PREVENTED INFLUENZA A AND B IN CHILDREN 6 TO 35 MONTHS OF AGE‍​ * STUDY MET ITS TWO PRIMARY ENDPOINTS * ‍STUDY ALSO FOUND THAT IIV4 REDUCED IMPACT OF INFLUENZA ON HEALTHCARE UTILISATION AND DAILY ACTIVITIES​ * FLURIX TETRA EFFICACY AGAINST MODERATE-TO-SEVERE INFLUENZA WAS 77.6% Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)",
    "published": "2018-03-06T13:01:00.000+02:00",
    "crawled": "2018-03-06T13:37:35.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "minute",
        "new",
        "data",
        "phase",
        "iii",
        "clinical",
        "trial",
        "fluarix",
        "tetra",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "glaxosmithkline",
        "plc",
        "announced",
        "new",
        "data",
        "phase",
        "iii",
        "clinical",
        "trial",
        "fluarix",
        "tetra",
        "prevented",
        "influenza",
        "b",
        "child",
        "month",
        "study",
        "met",
        "two",
        "primary",
        "endpoint",
        "also",
        "found",
        "iiv4",
        "reduced",
        "impact",
        "influenza",
        "healthcare",
        "utilisation",
        "daily",
        "flurix",
        "tetra",
        "efficacy",
        "influenza",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}